azoxymethane has been researched along with tryptophan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, T; Hoshi, M; Ito, H; Moriwaki, H; Nagano, J; Ninomiya, S; Ogawa, K; Saito, K; Sakai, H; Seishima, M; Shimizu, M; Tanaka, T; Tsurumi, H | 1 |
| Ding, Y; Du, Q; Hu, R; Liu, X; Zhang, X; Zhou, W | 1 |
2 other study(ies) available for azoxymethane and tryptophan
| Article | Year |
|---|---|
Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Carcinogens; Colonic Neoplasms; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Precancerous Conditions; Rats; Rats, Inbred F344; Tryptophan | 2012 |
1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.
Topics: Animals; Apoptosis; Azoxymethane; Carcinogens; Cdc20 Proteins; Cell Cycle; Cell Proliferation; Colitis; Colonic Neoplasms; Enzyme Inhibitors; Homeodomain Proteins; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitosis; Tryptophan; Tumor Cells, Cultured | 2018 |